Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opicapone Extension Study in Parkinson's Disease
NCT01851850Phase 3Completed
- Sponsor
- Rabin Medical Center
- Start
- May 2013
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of opicapone in Parkinson's disease (PD), sponsored by Rabin Medical Center. Started May 2013; status: completed.
02
Drugs
opicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01851850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01851850.